\-\ Texto\\:\\ \ \(0\)\
\-\ pain\\ over\\ right\\ hip\\ and\\ with\\ flexion\\ and\\ extension\\ at\\ the\\ waist\\.\ \(0\)\
\-\ treatment\\ is\\ primarily\\ by\\ surgical\\ resection\\ with\\ radiotherapy\\ and\\ chemotherapy\\.\\ \\ \\ this\\ patient\\ is\\ newly\\ diagnosed\\ and\\ the\\ specific\\ treatment\\ and\\ followup\\ plan\\ has\\ not\\ yet\\ been\\ established\\.\ \(0\)\
\-\ on\\ conventional\\ radiographs\\ this\\ lesion\\ is\\ characteristically\\ permeative\\ with\\ poorly\\ defined\\ margins\\,\\ often\\ lytic\\.\\ \\ there\\ may\\ be\\ periosteal\\ new\\ bone\\ formation\\ with\\ an\\ \\‚\\Ä\\úonion\\ skin\\‚\\Ä\\ù\\ appearance\\.\\ \\ ct\\ and\\ mri\\ clearly\\ delineate\\ the\\ often\\ very\\ large\\ soft\\ tissue\\ component\\,\\ especially\\ in\\ the\\ flat\\ bones\\ of\\ the\\ pelvis\\ and\\ thoracic\\ cage\\.\\ \\ bone\\ scintigraphy\\ is\\ useful\\ for\\ the\\ early\\ detection\\ of\\ bone\\ metastases\\.\\ \\ metastatic\\ lesions\\ are\\ seen\\ in\\ the\\ lung\\,\\ skeletal\\ system\\,\\ and\\ lymph\\ nodes\\ and\\ are\\ present\\ in\\ 15\\-25\\%\\ of\\ children\\ at\\ presentation\\.\ \(0\)\
\-\ \\ \\ mri\\ is\\ valuable\\ for\\ assessing\\ medullary\\ extension\\ and\\ the\\ soft\\-tissue\\ component\\ of\\ the\\ tumor\\.\\ \\ the\\ soft\\-tissue\\ component\\ of\\ the\\ tumor\\ decreases\\ after\\ therapy\\,\\ but\\ the\\ medullary\\ abnormality\\ remains\\.\\ \\ dynamic\\ enhanced\\ mri\\ has\\ been\\ used\\ to\\ assess\\ tumor\\ response\\.\ \(0\)\
\-\ ewing\\ sarcoma\ \(0\)\
\-\ ewing\\ sarcoma\ \(0\)\
\-\ non\\-hodgkin\\ lymphoma\ \(0\)\
\-\ osteosarcoma\ \(92\)\
\-\ osteomyelitis\ \(170\)\
\-\ metastatic\\ neuroblastoma\ \(2\)\
\-\ 13\\ yo\\ female\\ with\\ right\\ hip\\ and\\ pelvis\\ pain\\.\ \(1\)\
\-\ this\\ is\\ a\\ good\\ example\\ of\\ the\\ aggressiveness\\ of\\ ewing\\ sarcoma\\ \\ as\\ well\\ as\\ how\\ large\\ an\\ associated\\ soft\\ tissue\\ mass\\ can\\ be\\.\\ \\ the\\ imaging\\ findings\\ alone\\ cannot\\ diagnose\\ ewing\\ sarcoma\\,\\ but\\ they\\ do\\ demonstrate\\ a\\ very\\ aggressive\\ process\\ consistent\\ with\\ a\\ malignant\\ process\\.\\ \\ biopsy\\ showed\\ a\\ ewing\\ sarcoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ewing\\:\\ 0\\.10422309732092407\ \(0\)\
\-\ sarcoma\\:\\ 0\\.07579448465876977\ \(0\)\
\-\ component\\:\\ 0\\.046647771373272265\ \(0\)\
\-\ soft\\-tissue\\:\\ 0\\.0410514484289789\ \(0\)\
\-\ aggressiveness\\:\\ 0\\.03512158734648007\ \(0\)\
\-\ medullary\\:\\ 0\\.032717037630710474\ \(0\)\
\-\ onion\\:\\ 0\\.030744645957364095\ \(0\)\
\-\ 15\\-25\\:\\ 0\\.029598502242416763\ \(0\)\
\-\ hip\\:\\ 0\\.02712248902080843\ \(0\)\
\-\ permeative\\:\\ 0\\.02636770456824812\ \(0\)\
\-\ process\\:\\ 0\\.026215661233742745\ \(0\)\
\-\ valuable\\:\\ 0\\.025568219725769434\ \(0\)\
\-\ bone\\:\\ 0\\.025379697387966572\ \(0\)\
\-\ waist\\:\\ 0\\.025221560853300788\ \(0\)\
\-\ cage\\:\\ 0\\.024902665603605423\ \(0\)\
\-\ pelvis\\:\\ 0\\.024741764195949232\ \(0\)\
\-\ very\\:\\ 0\\.024715423254638477\ \(0\)\
\-\ extension\\:\\ 0\\.02430539698152712\ \(0\)\
\-\ delineate\\:\\ 0\\.024075417138353452\ \(0\)\
\-\ tumor\\:\\ 0\\.02381154145351567\ \(0\)\
\-\ mri\\:\\ 0\\.023465448465114978\ \(0\)\
\-\ characteristically\\:\\ 0\\.023390754760159595\ \(0\)\
\-\ assessing\\:\\ 0\\.02318639900562752\ \(0\)\
\-\ decreases\\:\\ 0\\.02318639900562752\ \(0\)\
\-\ newly\\:\\ 0\\.022629578518077086\ \(0\)\
\-\ non\\-hodgkin\\:\\ 0\\.022629578518077086\ \(0\)\
\-\ dynamic\\:\\ 0\\.021990763179132147\ \(0\)\
\-\ often\\:\\ 0\\.021724888832825914\ \(0\)\
\-\ diagnose\\:\\ 0\\.021571000168543197\ \(0\)\
\-\ plan\\:\\ 0\\.020844619464184814\ \(0\)\
\-\ established\\:\\ 0\\.020844619464184814\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.020735460204471208\ \(0\)\
\-\ how\\:\\ 0\\.02013672632778062\ \(0\)\
\-\ flat\\:\\ 0\\.019955601331458878\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.01978235387353163\ \(0\)\
\-\ detection\\:\\ 0\\.01978235387353163\ \(0\)\
\-\ conventional\\:\\ 0\\.0193036912765513\ \(0\)\
\-\ yet\\:\\ 0\\.019084329614467523\ \(0\)\
\-\ example\\:\\ 0\\.01874360382387724\ \(0\)\
\-\ been\\:\\ 0\\.01852426206744216\ \(0\)\
\-\ alone\\:\\ 0\\.0184297357846218\ \(0\)\
\-\ primarily\\:\\ 0\\.017867669656096284\ \(0\)\
\-\ useful\\:\\ 0\\.017764181662457794\ \(0\)\
\-\ remains\\:\\ 0\\.017713428571711064\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.017713428571711064\ \(0\)\
\-\ clearly\\:\\ 0\\.017516644685935858\ \(0\)\
\-\ metastatic\\:\\ 0\\.017140313973036576\ \(0\)\
\-\ assess\\:\\ 0\\.01706342203511252\ \(0\)\
\-\ response\\:\\ 0\\.01706342203511252\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.017020811321499976\ \(0\)\
\-\ skeletal\\:\\ 0\\.016814336947537485\ \(0\)\
\-\ aggressive\\:\\ 0\\.016656531616481524\ \(0\)\
\-\ poorly\\:\\ 0\\.01661803794751046\ \(0\)\
\-\ soft\\:\\ 0\\.016581089752936654\ \(0\)\
\-\ followup\\:\\ 0\\.01625227081901196\ \(0\)\
\-\ periosteal\\:\\ 0\\.016148782825373475\ \(0\)\
\-\ tissue\\:\\ 0\\.016138814250618277\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.01582203720122672\ \(0\)\
\-\ flexion\\:\\ 0\\.01566819323259015\ \(0\)\
\-\ margins\\:\\ 0\\.015462328648748233\ \(0\)\
\-\ can\\:\\ 0\\.015444002808518483\ \(0\)\
\-\ nodes\\:\\ 0\\.015377256439702142\ \(0\)\
\-\ 13\\:\\ 0\\.015377256439702142\ \(0\)\
\-\ lytic\\:\\ 0\\.015239385805528931\ \(0\)\
\-\ large\\:\\ 0\\.014888784317379122\ \(0\)\
\-\ do\\:\\ 0\\.014779175099864213\ \(0\)\
\-\ children\\:\\ 0\\.01470738822535155\ \(0\)\
\-\ enhanced\\:\\ 0\\.01456758217032657\ \(0\)\
\-\ good\\:\\ 0\\.01456758217032657\ \(0\)\
\-\ metastases\\:\\ 0\\.014544750796984002\ \(0\)\
\-\ but\\:\\ 0\\.014521938653653687\ \(0\)\
\-\ bones\\:\\ 0\\.014366662434761264\ \(0\)\
\-\ defined\\:\\ 0\\.014344950861982122\ \(0\)\
\-\ specific\\:\\ 0\\.014072966913260996\ \(0\)\
\-\ formation\\:\\ 0\\.014052794395505828\ \(0\)\
\-\ especially\\:\\ 0\\.014012753216806619\ \(0\)\
\-\ treatment\\:\\ 0\\.013781808443034956\ \(0\)\
\-\ lymph\\:\\ 0\\.013743196848385047\ \(0\)\
\-\ is\\:\\ 0\\.013441213825929697\ \(0\)\
\-\ system\\:\\ 0\\.013404302670919513\ \(0\)\
\-\ thoracic\\:\\ 0\\.013123735084080684\ \(0\)\
\-\ skin\\:\\ 0\\.013076210897366446\ \(0\)\
\-\ used\\:\\ 0\\.013060494649195066\ \(0\)\
\-\ has\\:\\ 0\\.012786453948161577\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.012715143098721751\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.012643869932384002\ \(0\)\
\-\ abnormality\\:\\ 0\\.01255999180808985\ \(0\)\
\-\ diagnosed\\:\\ 0\\.012518705803964166\ \(0\)\
\-\ early\\:\\ 0\\.012450832548376246\ \(0\)\
\-\ malignant\\:\\ 0\\.012305460862068927\ \(0\)\
\-\ they\\:\\ 0\\.012266717635407594\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.012202971255541296\ \(0\)\
\-\ biopsy\\:\\ 0\\.012078459130026935\ \(0\)\
\-\ new\\:\\ 0\\.011863697118727324\ \(0\)\
\-\ presentation\\:\\ 0\\.011726695754944552\ \(0\)\
\-\ this\\:\\ 0\\.011487695776662945\ \(0\)\
\-\ showed\\:\\ 0\\.011162562820413134\ \(0\)\
\-\ radiographs\\:\\ 0\\.010781955542637979\ \(0\)\
\-\ resection\\:\\ 0\\.010617193846694099\ \(0\)\
\-\ be\\:\\ 0\\.010500053572461587\ \(0\)\
\-\ as\\:\\ 0\\.010299422357722134\ \(0\)\
\-\ yo\\:\\ 0\\.01024442837969228\ \(0\)\
\-\ lung\\:\\ 0\\.00986119171409859\ \(0\)\
\-\ not\\:\\ 0\\.009839192603521398\ \(0\)\
\-\ appearance\\:\\ 0\\.00973667958858423\ \(0\)\
\-\ lymphoma\\:\\ 0\\.00972987503740831\ \(0\)\
\-\ an\\:\\ 0\\.009415656289121353\ \(0\)\
\-\ are\\:\\ 0\\.009281863526132285\ \(0\)\
\-\ at\\:\\ 0\\.009225204405032932\ \(0\)\
\-\ lesions\\:\\ 0\\.009113786877864334\ \(0\)\
\-\ therapy\\:\\ 0\\.009102154566695669\ \(0\)\
\-\ over\\:\\ 0\\.008667898765497858\ \(0\)\
\-\ consistent\\:\\ 0\\.008347801867853399\ \(0\)\
\-\ pain\\:\\ 0\\.00831560292853175\ \(0\)\
\-\ associated\\:\\ 0\\.008033715386086462\ \(0\)\
\-\ imaging\\:\\ 0\\.007976389738866942\ \(0\)\
\-\ \\%\\:\\ 0\\.007941518061139472\ \(0\)\
\-\ and\\:\\ 0\\.00788884088866296\ \(0\)\
\-\ demonstrate\\:\\ 0\\.007834470682601756\ \(0\)\
\-\ the\\:\\ 0\\.007711115481477136\ \(0\)\
\-\ well\\:\\ 0\\.00770151774091096\ \(0\)\
\-\ present\\:\\ 0\\.007689277904110282\ \(0\)\
\-\ may\\:\\ 0\\.007467443700789338\ \(0\)\
\-\ findings\\:\\ 0\\.0072463622939839024\ \(0\)\
\-\ right\\:\\ 0\\.007184316407254316\ \(0\)\
\-\ surgical\\:\\ 0\\.007156262032874317\ \(0\)\
\-\ after\\:\\ 0\\.007043829492466942\ \(0\)\
\-\ female\\:\\ 0\\.006999044906166668\ \(0\)\
\-\ lesion\\:\\ 0\\.006934482972113365\ \(0\)\
\-\ seen\\:\\ 0\\.006727600060030638\ \(0\)\
\-\ \\,\\:\\ 0\\.006471156944636351\ \(0\)\
\-\ a\\:\\ 0\\.006320315566830299\ \(0\)\
\-\ for\\:\\ 0\\.005809626682412072\ \(0\)\
\-\ by\\:\\ 0\\.005668808379461652\ \(0\)\
\-\ there\\:\\ 0\\.0050665958424899946\ \(0\)\
\-\ in\\:\\ 0\\.005036620280560816\ \(0\)\
\-\ ct\\:\\ 0\\.0047621659497690955\ \(0\)\
\-\ mass\\:\\ 0\\.00473490441014966\ \(0\)\
\-\ patient\\:\\ 0\\.0034127168562405894\ \(0\)\
\-\ of\\:\\ 0\\.00324910998241402\ \(0\)\
\-\ on\\:\\ 0\\.002884027937710869\ \(0\)\
\-\ with\\:\\ 0\\.002796912575853938\ \(0\)\
\-\ \\.\\:\\ 0\\.0021214862209569486\ \(0\)\
\-\ to\\:\\ 0\\.0017014665675019372\ \(0\)\
